文献速递临床微生物分子诊断

2016-2019年韩国大学医院直肠与临床样本产碳青霉烯酶肠杆菌的基因型分布及抗菌药物敏感性

Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing Enterobacteriaceae Isolated From Rectal and Clinical Samples in Korean University Hospitals Between 2016 and 2019.
PubMed 文献 · Ann Lab Med · 2022-01-01

该研究分析了2016年1月至2019年12月韩国四所大学医院分离的1,254株非重复产碳青霉烯酶肠杆菌(CPE),用多重实时PCR确定基因型,Vitek 2或MicroScan Walkaway-96系统检测药敏。结果显示KPC占38.8%、OXA-48-like占29.6%、NDM占28.5%,主要菌种为肺炎克雷伯菌(72.6%);携带KPC、NDM和OXA-48-like的分离株中超过90%对头孢菌素、氨曲南和碳青霉烯类不敏感。

要点

  • CPE以KPC、OXA-48-like和NDM型为主,肺炎克雷伯菌占72.6%。
  • 携带KPC、NDM或OXA-48-like的菌株多对头孢菌素、氨曲南和碳青霉烯类不敏感。
  • 需基于基因型分布和药敏特征制定防控策略。

核心结论

  • CPE的影响主要来自产KPC、NDM和OXA-48-like的肺炎克雷伯菌,这些菌株多表现为多重耐药。

研究设计与样本

  • 2016年1月至2019年12月在韩国四所大学医院收集1,254株非重复CPE分离株,用多重实时PCR确定碳青霉烯酶基因型,用Vitek 2或MicroScan Walkaway-96系统进行药敏试验,采用Pearson卡方检验分析比例。

主要发现

  • 1,254株CPE中KPC 486株(38.8%)、OXA-48-like 371株(29.6%)、NDM 357株(28.5%)、IMP 8株(0.6%)、VIM 8株(0.6%)、多重产酶菌24株(1.9%)。
  • 主要菌种为肺炎克雷伯菌(72.6%),其次为大肠埃希菌(6.5%)。
  • 携带KPC、NDM和OXA-48-like的分离株中超过90%对头孢菌素、氨曲南和碳青霉烯类不敏感。

关键数值与推荐

  • KPC占38.8%、OXA-48-like占29.6%、NDM占28.5%、IMP占0.6%、VIM占0.6%、多重产酶菌占1.9%。
  • 肺炎克雷伯菌占72.6%,大肠埃希菌占6.5%。
  • 携带KPC、NDM和OXA-48-like的菌株中超过90%对头孢菌素、氨曲南和碳青霉烯类不敏感。

临床怎么用

  • 实验室应关注KPC、NDM和OXA-48-like型CPE的检测与分型,以指导感染控制和用药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The emergence of carbapenemase-producing Enterobacteriaceae (CPE) represents a major clinical problem. Recently, the occurrence of CPE has increased globally, but epidemiological patterns vary across region. We report the trends in the genotypic distribution and antimicrobial susceptibility of CPE isolated from rectal and clinical samples during a four-year period. METHODS: Between January 2016 and December 2019, 1,254 nonduplicated CPE isolates were obtained from four university hospitals in Korea. Carbapenemase genotypes were determined by multiplex real-time PCR. Antimicrobial susceptibility was profiled using the Vitek 2 system (bioMérieux, Hazelwood, MO, USA) or MicroScan Walkaway-96 system (Siemens West Sacramento, CA, USA). The proportions of carbapenemase genotypes and nonsusceptibility were analyzed using Pearson's chi-square test. RESULTS: Among the 1,254 CPE isolates, 486 (38.8%), 371 (29.6%), 357 (28.5%), 8 (0.6%), 8 (0.6%), and 24 (1.9%) were Klebsiella pneumoniae carbapenemase (KPC), oxacillinase (OXA)-48-like, New Delhi metallo-β-lactamase (NDM), imipenemase (IMP), Verona integron-encoded metallo-β-lactamase (VIM), and multiple producers, respectively. The predominant species was K. pneumoniae (72.6%), followed by Escherichia coli (6.5%). More than 90% of the isolates harboring KPC, NDM, and OXA-48-like were nonsusceptible to cephalosporins, aztreonam, and carbapenems. CONCLUSIONS: The impact of CPE is primarily due to KPC-, NDM-, and OXA-48-like-producing K. pneumoniae isolates. Isolates carrying these carbapenemase are mostly multidrug-resistant. Control strategies based on these genotypic distributions and antimicrobial susceptibilities of CPE isolates are required.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Jeong S, Lee N, Park MJ, et al. Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing Enterobacteriaceae Isolated From Rectal and Clinical Samples in Korean University Hospitals Between 2016 and 2019. Ann Lab Med. 2022. PMID: 34374347. doi:10.3343/alm.2022.42.1.36

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。